The Net Margin of Halozyme Therapeutics Inc (HALO) is 43.74%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | 43.74% |
| 2023-12-31 | 33.96% |
| 2022-12-31 | 30.62% |
| 2021-12-31 | 90.84% |
| 2020-12-31 | 48.24% |
| 2019-12-31 | -36.84% |
| 2018-12-31 | -52.86% |
| 2017-12-31 | 19.90% |
| 2016-12-31 | -70.21% |
| 2015-12-31 | -23.83% |